Repeated head impacts cause early neuron loss and inflammation in young athletes
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Dec-2025 09:11 ET (26-Dec-2025 14:11 GMT/UTC)
Researchers have developed an AI model that estimates long-term disease risk across more than 1,000 medical conditions
The model, trained and tested on anonymised medical data from the UK and Denmark, can forecast health outcomes over a decade in advance
While not ready for direct clinical use, the AI model offers new ways to study disease and inform healthcare strategies
When brain development gets off to a bad start, the consequences are lifelong.
One example is a condition called SCN2A haploinsufficiency, in which children are born with just one functioning copy of the SCN2A gene — instead of the normal two. They develop defects in the connections, or synapses, between some of their brain cells; they do not learn to speak; and many of them experience seizures.
Center for BrainHealth and The University of Texas at Dallas are pioneering a new approach to sleep research with the launch of the Sleep Innovation Laboratories, a visionary research initiative uniting science, technology and human performance to unlock the transformative power of sleep on brain health. Spearheading this initiative is internationally acclaimed neuroscientist and sleep expert Matthew Walker, PhD, who joins January 1, 2026, as the laboratories’ inaugural director and professor of neuroscience and biomedical engineering at UT Dallas’ School of Behavioral and Brain Sciences and Erik Jonsson School of Engineering and Computer Science.
Human papillomavirus (HPV) is the primary cause of virus-associated cancers, especially cervical and head and neck cancers. A key mechanism involves the integration of HPV DNA into the host genome. To support the WHO's strategy to eliminate cervical cancer, understanding HPV integration is crucial. This summary highlights current insights into the mechanisms of HPV integration, their clinical implications, and emerging therapeutic strategies aimed at enhancing precision oncology for HPV-related cancers.